Company intelligence / Profile preview

Perceiv AI

Montreal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

Perceiv AI's Foresight platform uses AI/ML on multimodal patient data to forecast disease evolution and optimize clinical trials, especially in Alzheimer's and related neurodegenerative diseases. The platform has been validated for improving patient selection and trial enrichment, but does not currently develop therapeutics itself.

Therapeutic areas: CardiovascularNeurology
Industry: Drug Discovery Services

Partnerships

Centre for Aging + Brain Health Innovation (CABHI)Plug and Play VenturesNVIDIA Inception ProgramITEA 3 Secure-e-Health ConsortiumStartUp Health

Beyond the preview

Go deeper on Perceiv AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perceiv AI.

Explore the full profile